Usted buscó: cross the placenta (Inglés - Maltés)

atosiban passes the placenta.
atosiban jgħaddi mill-plaċenta.

- if the placenta is detaching
qabel ma ’ tuŻa tractocile

abatacept was shown to cross the placenta in rats and rabbits.
Ġie muri li abatacept jaqsam il-plaċenta fil-fniek u l-firien.

in animal studies, vemurafenib was found to cross the placenta.
fi studji fuq l-annimali, vemurafenib instab li jgħaddi mill-plaċenta.

elbasvir has been shown to cross the placenta in rats and rabbits.
elbasvir intwera li jgħaddi mill- plaċenta fil-firien u fil-fniek.

in rat studies, it was shown that pegfilgrastim may cross the placenta.
fi studji fil-firien, intwera li pegfilgrastim għandu mnejn jgħaddi mis-sekonda.

glimepiride is transferred to the placenta.
glimepiride jiġi trasferit għal ġol-plaċenta.

pseudoephedrine sulphate is presumed to cross the placenta and the haematoencephalic barrier.
jista’ jiġi assumat li pseudoephedrine sulphate jaqsam mill-plaċenta u l-barriera ematoenċefalika.

pitolisant/metabolites were shown to cross the placenta barrier in animals.
pitolisant/il-metaboliti ntwerew li jaqsmu l-barriera tal-plaċenta fl-annimali.

cabazitaxel crossed the placenta barrier in rats.
fil-firien, cabazitaxel jgħaddi minn ġol-plaċenta.

in reproductive toxicity studies in animals, dolutegravir was shown to cross the placenta.
fi studji tal-effett tossiku fuq is-sistema riproduttiva fl- annimali, dolutegravir intwera li jgħaddi minn ġol-plaċenta.

however, daptomycin can cross the placenta in pregnant rats (see section 5.2).
madankollu, daptomycin jista’ jgħaddi minn ġol- plaċenta fil-firien waqt it-tqala (ara sezzjoni 5.2).

human data show that tacrolimus crosses the placenta.
tagħrif mill-bniedem juri li tacrolimus jaqsam il-plaċenta.

igg1 monoclonal antibodies are known to cross the placenta after the first trimester of pregnancy.
antikorpi monoklonali igg1 huma magħrufa li jgħaddu minn ġol-plaċenta wara l-ewwel trimestru tat-tqala.

in reproductive toxicity studies in animals, lamivudine and abacavir were shown to cross the placenta.
fi studji dwar it-tossiċita fis-sistema riproduttiva fl-annimali, lamivudine u abacavir jidher li qasmu l- plaċenta.

in humans, midazolam has been shown to cross the placenta slowly and to enter foetal circulation.
intwera li fil-bnedmin, midazolam jgħaddi mill-plaċenta bil-mod u jidħol fiċ-ċirkolazzjoni tal-fetu.

abatacept may cross the placenta into the serum of infants born to women treated with abatacept during pregnancy.
abatacept jista’ jaqsam il-plaċenta fis-serum tat-trabi li twieldu minn nisa kkurati b’abatacept waqt it- tqala.

doxycycline is known to cross the placenta and literature data indicate that tetracyclines can have toxic effects on the developing fetus.
doxycycline huwa magħruf li jgħaddi mis- sekonda u tagħrif mil- letteratura jindika li tetracyclines jista ’ jkollhom effetti tossiċi fuq il- fetu li qed jiżviluppa.

in rats, sorafenib and its metabolites were demonstrated to cross the placenta and sorafenib is anticipated to cause harmful effects on the foetus.
fil- firien, sorafenib u l- metaboliti tiegħu intwerew li jgħaddu mill- plaċenta u sorafenib mistenni li jikkawża effetti ħżiena fuq il- fetu.

human igg1 is known to cross the placenta; therefore, necitumumab has the potential to be transmitted from the mother to the developing foetus.
igg1 uman huwa magħruf li jgħaddi minn ġol-plaċenta; għalhekk, necitumumab għandu l- possibbiltà li jiġi ttrasferit mill-omm għall-fetu li jkun qed jiżviluppa.